King Pharmaceuticals KG AmTrust Legacy Segment — Net premiums earned
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's amtrust legacy segment — net premiums earned.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's amtrust legacy segment — net premiums earned?
- King Pharmaceuticals (KG) reported amtrust legacy segment — net premiums earned of $2.29M in Q1 2026.
- What does amtrust legacy segment — net premiums earned mean?
- This metric measures the portion of net premiums written that is recognized as revenue by the AmTrust Legacy segment over the duration of the insurance policy coverage period. It reflects the actual earned revenue generated from the segment's underwriting operations, providing a more accurate view of ongoing financial performance than written premiums alone. Investors use this to evaluate the segment's core profitability and the stability of its revenue streams as policies mature.